Encapsulate Awarded $3.63M NASA InSPA Phase 1 Grant to Develop Microgravity-Based Metastasis-on-a-Chip Technology Farmington, CT – Encapsulate, Inc., a precision medicine startup developing advanced biochip systems, has been awarded a $3.63 million Phase 1 grant...
Encapsulate Awarded $1.25M NSF SBIR Phase II Grant to Advance Automated Chemotherapy Selection Platform for Pancreatic and Colorectal Cancers Farmington, CT – Encapsulate, Inc., a precision medicine startup developing automated biochip systems for personalized cancer...
Encapsulate Closes $1.8M Oversubscribed Seed Round to Accelerate Personalized Cancer Therapy Farmington, CT – Encapsulate, a developer of personalized oncology solutions, has raised $1.8 million in seed funding, led by Blackwood Healthcare Breakthroughs, Ambit Health...
We are thrilled to announce that Encapsulate has secured 2nd place and a $75,000 cash prize at the 2024 Entrepreneurship World Cup Global Finals!Competing among the top 100 startups from 52 countries, Encapsulate was recognized for our advanced tumor-on-a-chip...
We are thrilled that we have presented at the ISSRDC conference in Boston with our groundbreaking study: “Encapsulate: Automated Biochips for Personalized Cancer Screening in Microgravity”.For the first time, we’ll be sharing the incredible data...
